166 related articles for article (PubMed ID: 7494329)
1. Transcriptional transactivation of parvovirus B19 promoters in nonpermissive human cells by adenovirus type 2.
Ponnazhagan S; Woody MJ; Wang XS; Zhou SZ; Srivastava A
J Virol; 1995 Dec; 69(12):8096-101. PubMed ID: 7494329
[TBL] [Abstract][Full Text] [Related]
2. Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: human megakaryocytic leukaemia cells are non-permissive for AAV infection.
Ponnazhagan S; Wang XS; Woody MJ; Luo F; Kang LY; Nallari ML; Munshi NC; Zhou SZ; Srivastava A
J Gen Virol; 1996 Jun; 77 ( Pt 6)():1111-22. PubMed ID: 8683195
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted expression from parvovirus B19p6 promoter in primary human hematopoietic progenitor cells.
Kurpad C; Mukherjee P; Wang XS; Ponnazhagan S; Li L; Yoder MC; Srivastava A
J Hematother Stem Cell Res; 1999 Dec; 8(6):585-92. PubMed ID: 10645765
[TBL] [Abstract][Full Text] [Related]
4. Parvovirus B19 promoter at map unit 6 confers autonomous replication competence and erythroid specificity to adeno-associated virus 2 in primary human hematopoietic progenitor cells.
Wang XS; Yoder MC; Zhou SZ; Srivastava A
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12416-20. PubMed ID: 8618912
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human parvovirus B19 vectors: erythroid cell-specific delivery and expression of transduced genes.
Ponnazhagan S; Weigel KA; Raikwar SP; Mukherjee P; Yoder MC; Srivastava A
J Virol; 1998 Jun; 72(6):5224-30. PubMed ID: 9573295
[TBL] [Abstract][Full Text] [Related]
6. Transactivation of human parvovirus B19 gene expression in endothelial cells by adenoviral helper functions.
Pozzuto T; von Kietzell K; Bock T; Schmidt-Lucke C; Poller W; Zobel T; Lassner D; Zeichhardt H; Weger S; Fechner H
Virology; 2011 Mar; 411(1):50-64. PubMed ID: 21236463
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cis-acting and NS1 protein-responsive elements in the p6 promoter of parvovirus B19.
Gareus R; Gigler A; Hemauer A; Leruez-Ville M; Morinet F; Wolf H; Modrow S
J Virol; 1998 Jan; 72(1):609-16. PubMed ID: 9420265
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells.
Weigel-Kelley KA; Yoder MC; Srivastava A
J Virol; 2001 May; 75(9):4110-6. PubMed ID: 11287560
[TBL] [Abstract][Full Text] [Related]
9. Simian virus 40 small-t does not transactivate RNA polymerase II promoters in virus infections.
Rajan P; Dhamankar V; Rundell K; Thimmapaya B
J Virol; 1991 Dec; 65(12):6553-61. PubMed ID: 1658360
[TBL] [Abstract][Full Text] [Related]
10. Transactivation of adenovirus E2-early promoter by E1A and E4 6/7 in the context of viral chromosome.
Swaminathan S; Thimmapaya B
J Mol Biol; 1996 May; 258(5):736-46. PubMed ID: 8637006
[TBL] [Abstract][Full Text] [Related]
11. Cellular GCN5 is a novel regulator of human adenovirus E1A-conserved region 3 transactivation.
Ablack JN; Cohen M; Thillainadesan G; Fonseca GJ; Pelka P; Torchia J; Mymryk JS
J Virol; 2012 Aug; 86(15):8198-209. PubMed ID: 22623781
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human parvovirus B19 vectors.
Weigel-Kelley KA; Srivastava A
Pathol Biol (Paris); 2002 Jun; 50(5):295-306. PubMed ID: 12116848
[TBL] [Abstract][Full Text] [Related]
13. The human papillomavirus type 16 E7 protein complements adenovirus type 5 E1A amino-terminus-dependent transactivation of adenovirus type 5 early genes and increases ATF and Oct-1 DNA binding activity.
Wong HK; Ziff EB
J Virol; 1996 Jan; 70(1):332-40. PubMed ID: 8523545
[TBL] [Abstract][Full Text] [Related]
14. Optimization of recombinant adeno-associated viral vectors for human beta-globin gene transfer and transgene expression.
Maina N; Zhong L; Li X; Zhao W; Han Z; Bischof D; Aslanidi G; Zolotukhin S; Weigel-Van Aken KA; Rivers AE; Slayton WB; Yoder MC; Srivastava A
Hum Gene Ther; 2008 Apr; 19(4):365-75. PubMed ID: 18399730
[TBL] [Abstract][Full Text] [Related]
15. Indiscriminate activity from the B19 parvovirus p6 promoter in nonpermissive cells.
Liu JM; Fujii H; Green SW; Komatsu N; Young NS; Shimada T
Virology; 1991 May; 182(1):361-4. PubMed ID: 2024472
[TBL] [Abstract][Full Text] [Related]
16. Promoter strength in adenovirus transducing vectors: down-regulation of the adenovirus E1A promoter in 293 cells facilitates vector construction.
Schaack J; Allen B; Orlicky DJ; Bennett ML; Maxwell IH; Smith RL
Virology; 2001 Dec; 291(1):101-9. PubMed ID: 11878880
[TBL] [Abstract][Full Text] [Related]
17. Comparison of promoter activity in Aleutian mink disease parvovirus, minute virus of mice, and canine parvovirus: possible role of weak promoters in the pathogenesis of Aleutian mink disease parvovirus infection.
Christensen J; Storgaard T; Viuff B; Aasted B; Alexandersen S
J Virol; 1993 Apr; 67(4):1877-86. PubMed ID: 8383215
[TBL] [Abstract][Full Text] [Related]
18. High-efficiency transduction of primary human hematopoietic stem cells and erythroid lineage-restricted expression by optimized AAV6 serotype vectors in vitro and in a murine xenograft model in vivo.
Song L; Li X; Jayandharan GR; Wang Y; Aslanidi GV; Ling C; Zhong L; Gao G; Yoder MC; Ling C; Tan M; Srivastava A
PLoS One; 2013; 8(3):e58757. PubMed ID: 23516552
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a cell line expressing human parvovirus B19 non-structural protein from an inducible promoter.
Leruez-Ville M; Vassias I; Pallier C; Cecille A; Hazan U; Morinet F
J Gen Virol; 1997 Jan; 78 ( Pt 1)():215-9. PubMed ID: 9010306
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic determinants of adenovirus E1A gene autoregulation: variable region between conserved coding domains 2 and 3.
Hamid R; Cogan JD; Jones SN; Tibbetts C
Virology; 1995 Nov; 213(2):666-70. PubMed ID: 7491791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
